🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12072+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12072 recruiting trials

NARecruitingNCT06694168

Efficacy of the Entire Papilla Preservation Technique With and Without the Use of L-PRF as a Regenerative Material for the Treatment of Infrabony Defects

👨‍⚕️ Andreas G Anwandter, DDS, Universidad de Los Andes📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06111950

Study of the Pathophysiology of RNU4ATAC and RTTN Associated Syndromes

👨‍⚕️ Sylvie MAZOYER, Dr📍 6 sites📅 Started Aug 2024View details ↗
NARecruitingNCT06222138

Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma

🏥 Institut Claudius Regaud📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT05984394

Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung Disease

👨‍⚕️ Paul Decker, MD, CHU NANCY📍 6 sites📅 Started Aug 2024View details ↗
RecruitingNCT06561178

Individualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)

👨‍⚕️ Hong Yang, M.D.;Ph.D., Sun Yat-Sen University Cancer Center📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06574282

Characteristics of Hypophosphatasia in Adult Patients in Rheumatology and Their Value in Developing an Algorithm to HPP-diagnosis - the COHIR Multi-center Study

👨‍⚕️ Valentin S. Schäfer, Univ.-Prof. Dr. med. MUDr., University Hospital of Bonn📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06566807

Oxygen Study-Orelabrutinib Combined With Obinutuzumab(O2) for First-Line Treatment of Marginal Zone Lymphoma

🏥 Huai'an First People's Hospital📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06570317

Nintedanib for the Prevention of Radiation Pneumonia in Unresectable NSCLC

👨‍⚕️ Gang Jin, Dr., Second Hospital of Shanxi Medical University📍 7 sites📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06553872

Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL

👨‍⚕️ Michael Jain, MD, PhD, Moffitt Cancer Center📍 3 sites📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06440993

Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma

👨‍⚕️ Salah-Eddin SE Al-Batran, Prof. Dr., Frankfurter Institut fuer Klinische Krebsforschung IKF GmbH📍 10 sites📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06647901

Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study

🏥 Tang Xiaodong📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT05583071

Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL

🏥 University of Cologne📍 6 sites📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06686043

HPV Vaccine, Imiquimod, and Metformin Combination Trial

👨‍⚕️ Jan S Sunde, MD, Baylor College of Medicine📍 2 sites📅 Started Aug 2024View details ↗
Phase 1RecruitingNCT06608355

The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease

🏥 iRegene Therapeutics Co., Ltd.📍 1 site📅 Started Aug 2024View details ↗
Phase 1RecruitingNCT06589609

Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer

🏥 BlueSky Immunotherapies GmbH📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06331208

Mechanisms of Pulmonary Vascular Dysfunction in Heart Failure

👨‍⚕️ Vojtech Melenovsky, Institute for Clinical and Experimental Medicine📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06191198

Communication Bridge 3 Study

👨‍⚕️ Emily Roglaski, PhD, Professor of Neurology📍 1 site📅 Started Aug 2024View details ↗
NAEnrolling by InvitationNCT05941559

EMDR for Persistent Pain in RA

🏥 Medisch Spectrum Twente📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06546631

Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients

🏥 University College Cork📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06535607

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

🏥 AstraZeneca📍 59 sites📅 Started Aug 2024View details ↗
← PreviousPage 251 of 604Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →